| 51 |
12160192 | Decreases in serum uric acid by amelioration of insulin resistance in overweight hypertensive patients: effect of a low-energy diet and an insulin-sensitizing agent. | 2002 Aug |
1 |
| 52 |
12196460 | Troglitazone treatment increases protein kinase B phosphorylation in skeletal muscle of normoglycemic subjects at risk for the development of type 2 diabetes. | 2002 Sep |
2 |
| 53 |
12196473 | Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. | 2002 Sep |
3 |
| 54 |
12351424 | Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. | 2002 Oct |
7 |
| 55 |
12393300 | Troglitazone: the discovery and development of a novel therapy for the treatment of Type 2 diabetes mellitus. | 2002 Nov 5 |
1 |
| 56 |
15765620 | Potential utility of insulin sensitizers in the treatment of patients with Polycystic ovary syndrome. | 2002 |
1 |
| 57 |
11162573 | Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells. | 2001 Jan 26 |
2 |
| 58 |
11205931 | Improvement of left ventricular diastolic dynamics in prediabetic stage of a type II diabetic rat model after troglitazone treatment. | 2001 Jan |
1 |
| 59 |
11206412 | Distinct long-term regulation of glycerol and non-esterified fatty acid release by insulin and TNF-alpha in 3T3-L1 adipocytes. | 2001 Jan |
1 |
| 60 |
11288035 | Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial. | 2001 Apr |
2 |
| 61 |
11292061 | Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in hepG2 cells. | 2001 Mar 9 |
2 |
| 62 |
11297595 | Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. | 2001 Apr |
2 |
| 63 |
11315852 | Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM. | 2001 Apr |
1 |
| 64 |
11329231 | The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial. | 2001 May 1 |
1 |
| 65 |
11334413 | Troglitazone induces GLUT4 translocation in L6 myotubes. | 2001 May |
2 |
| 66 |
11368854 | Combined effects of troglitazone and muscle contraction on insulin sensitization in Balb-c mouse muscle. | 2001 May |
4 |
| 67 |
11407727 | Beneficial effect of troglitazone, an insulin-sensitizing antidiabetic agent, on coronary circulation in patients with non-insulin-dependent diabetes mellitus. | 2001 Jun |
4 |
| 68 |
11422732 | Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. | 2001 Jul |
1 |
| 69 |
11438619 | Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients. | 2001 Jul |
3 |
| 70 |
11443198 | Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? | 2001 Jul |
2 |
| 71 |
11523631 | Mechanisms involved in tumor necrosis factor-alpha induction of insulin resistance and its reversal by thiazolidinedione(s). | 2001 Aug |
1 |
| 72 |
11689273 | Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation--double-blind placebo-controlled trial. | 2001 Dec |
1 |
| 73 |
11719831 | Troglitazone selectively inhibits glyoxalase I gene expression. | 2001 Nov |
1 |
| 74 |
11779345 | Synergistic antiadipogenic effects of HIV type 1 protease inhibitors with tumor necrosis factor alpha: suppression of extracellular insulin action mediated by extracellular matrix-degrading proteases. | 2001 Nov 20 |
2 |
| 75 |
11798015 | Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells. | 2001 Dec 14 |
1 |
| 76 |
10690939 | Inhibitory effect of troglitazone on tumor necrosis factor alpha-induced expression of monocyte chemoattractant protein-1 in human mesangial cells. | 2000 Feb |
1 |
| 77 |
10707563 | [Troglitazone]. | 2000 Feb |
1 |
| 78 |
10707570 | [Dyslipidemia in insulin resistance and its improvement by troglitazone]. | 2000 Feb |
1 |
| 79 |
10707572 | [Cardiovascular effects of the thiazolidinedione troglitazone]. | 2000 Feb |
2 |
| 80 |
10707578 | [Troglitazone for treatment of polycystic ovary syndrome]. | 2000 Feb |
1 |
| 81 |
10770198 | Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells. | 2000 Apr |
1 |
| 82 |
10802155 | Inhibitory effect of troglitazone on TNF-alpha-induced expression of monocyte chemoattractant protein-1 (MCP-1) in human endothelial cells. | 2000 Jun |
1 |
| 83 |
10807673 | Troglitazone prevents and reverses dexamethasone induced insulin resistance on glycogen synthesis in 3T3 adipocytes. | 2000 May |
5 |
| 84 |
10813377 | Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. | 2000 May |
3 |
| 85 |
10814527 | Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. | 2000 May 19 |
3 |
| 86 |
10815754 | Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus. | 2000 Apr |
2 |
| 87 |
10831180 | Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus. | 2000 May |
2 |
| 88 |
10857389 | Troglitazone and emerging glitazones: new avenues for potential therapeutic benefits beyond glycemic control. | 2000 |
1 |
| 89 |
10868865 | Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients. | 2000 Mar |
1 |
| 90 |
10871202 | Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. | 2000 Apr |
6 |
| 91 |
10905487 | Response of pancreatic beta-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. | 2000 May |
4 |
| 92 |
10917034 | [A 75-year-old type 2 diabetes mellitus case responding strikingly troglitazone: possible mechanism of insulin resistance induced by insulin antibody]. | 2000 Apr |
6 |
| 93 |
10937499 | Efficacy of troglitazone on body fat distribution in type 2 diabetes. | 2000 Aug |
3 |
| 94 |
10989325 | Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings. | 2000 May-Jun |
1 |
| 95 |
11016899 | Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes. | 2000 Sep |
6 |
| 96 |
11057433 | Effects of a low-energy diet and an insulin-sensitizing agent on ambulatory blood pressure in overweight hypertensive patients. | 2000 Oct |
1 |
| 97 |
11057434 | Glucose modifies the cross-talk between insulin and the beta-adrenergic signalling system in vascular smooth muscle cells. | 2000 Oct |
1 |
| 98 |
11065164 | Troglitazone and related compounds: therapeutic potential beyond diabetes. | 2000 Oct 6 |
2 |
| 99 |
11107871 | [New hypoglycemic drugs in treatment of diabetes type 2]. | 2000 |
1 |
| 100 |
11109896 | [Glitazones (thiazolidinedione)]. | 2000 Oct |
1 |